Back to Journals » Cancer Management and Research » Volume 13

miR-621 May Suppress Cell Proliferation via Targeting lncRNA SNHG10 in Acute Myeloid Leukemia

Authors Xiao S, Zha Y, Zhu H

Received 26 June 2020

Accepted for publication 4 December 2020

Published 2 March 2021 Volume 2021:13 Pages 2117—2123


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Antonella D'Anneo

Shishan Xiao,1,* Yan Zha,2,* Hongqian Zhu1

1Department of Hematology, Guizhou Provincial People’s Hospital, Guiyang City, Guizhou Province 550002, People’s Republic of China; 2Department of Nephrology, Guizhou Provincial People’s Hospital, Guiyang City, Guizhou Province 550002, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Hongqian Zhu
Guizhou Provincial People’s Hospital, No. 83 Zhongshan East Road, Guiyang City, Guizhou Province 550002, People’s Republic of China
Email [email protected]

Background: It has been reported that lncRNA SNHG10 (SNHG10) promotes the progression of liver cancer and osteosarcoma; however, the role of SNHG10 in acute myeloid leukemia (AML) remains unknown. This study was to explore the role of SNHG10 in AML.
Methods: The expression of SNHG10 and miR-621 in BM mononuclear cells (BMMNCs) isolated from 60 AML patients and 60 healthy controls were determined by RT-qPCR. Correlation between SNHG10 and miR-621 was analyzed by Pearson correlation coefficient. The overexpression of SNHG10 and miR-621 in transfected AML cells was detected by RT-qPCR, and the regulatory relationship between them was explored. Methylation-specific PCR (MSP) was applied to detect the methylation of miR-621 induced by the overexpression of SNHG10. CCK-8 assay was conducted to evaluate cell proliferation.
Results: In this study, we found that the expression of SNHG10 was upregulated and the expression of miR-621 was downregulated in AML samples. Moreover, SNHG10 and miR-621 were inversely correlated across AML samples, and a high level of SNHG10 predicted poor survival of AML patients. Bioinformatics analysis showed that SNHG10 could be targeted by miR-621. In AML cells, miR-621 overexpression downregulated the expression of SNHG10, while SNHG10 overexpression could not affect the expression of miR-621. However, it was found that the reduction of miR-621 caused by SNHG10 overexpression might be due to the increase of miR-621 methylation. In addition, SNHG10 overexpression significantly promoted BMMNC proliferation, whereas miR-621 overexpression inhibited BMMNC proliferation and abolished the effect of SNHG10 overexpression on BMMNC proliferation.
Conclusion: miR-621 targets SNHG10 to suppress cell proliferation in AML.

Keywords: acute myeloid leukemia, miR-621, SNHG10, proliferation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]